Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas

NCT01837862 is registered in ClinicalTrials.gov with Julie Krystal as lead sponsor.

NCT NCT01837862
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01837862 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas
Lead sponsor
Julie Krystal
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
October 22, 2013
Completion date
December 31, 2027
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anaplastic astrocytoma, brainstem glioma, diffuse intrinsic pontine glioma, dipg, glioblastoma multiforme, glioma, astrocytic, gliosarcoma, low-grade glioma, optic nerve glioma, pilocytic astrocytoma, pilomyxoid astrocytoma, pleomorphic xanthoastrocytoma